These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12468151)

  • 21. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
    Zwitter M; Kovac V; Smrdel U; Strojan P
    J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gemcitabine shows promise as combination agent in NSCLC.
    Oncology (Williston Park); 1996 Sep; 10(9):1311. PubMed ID: 9052981
    [No Abstract]   [Full Text] [Related]  

  • 23. Activity of single-agent gemcitabine as second-line treatment after previous chemotherapy or radiotherapy in advanced non-small-cell lung cancer.
    van Putten JW; Baas P; Codrington H; Kwa HB; Muller M; Aaronson N; Groen HJ
    Lung Cancer; 2001; 33(2-3):289-98. PubMed ID: 11551424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized phase III trial comparing single-agent paclitaxel Poliglumex (CT-2103, PPX) with single-agent gemcitabine or vinorelbine for the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer.
    O'Brien ME; Socinski MA; Popovich AY; Bondarenko IN; Tomova A; Bilynsky BT; Hotko YS; Ganul VL; Kostinsky IY; Eisenfeld AJ; Sandalic L; Oldham FB; Bandstra B; Sandler AB; Singer JW
    J Thorac Oncol; 2008 Jul; 3(7):728-34. PubMed ID: 18594318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pemetrexed plus platinum or gemcitabine plus platinum for advanced non-small cell lung cancer: final survival analysis from a multicentre randomized phase II trial in the East Asia region and a meta-analysis.
    Zhang X; Lu J; Xu J; Li H; Wang J; Qin Y; Ma P; Wei L; He J
    Respirology; 2013 Jan; 18(1):131-9. PubMed ID: 22882698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gemcitabine for lung cancer.
    Drug Ther Bull; 1996 Sep; 34(9):71-2. PubMed ID: 8885499
    [No Abstract]   [Full Text] [Related]  

  • 27. Gemcitabine in the first and second-line chemotherapy of advanced non-small cell lung cancer.
    Cucević B; Samarzija M; Baricević D; Jakopović M; Redzepi G; Samija M
    Coll Antropol; 2005 Dec; 29(2):583-8. PubMed ID: 16417165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current chemotherapy of advanced non-small cell lung cancer.
    Abratt RP
    Anticancer Drugs; 1995 Dec; 6 Suppl 6():15-8. PubMed ID: 8718420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module.
    Evans WK
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-56-S7-63. PubMed ID: 9194482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving quality of life in patients with non-small cell lung cancer: research experience with gemcitabine.
    Thatcher N; Hopwood P; Anderson H
    Eur J Cancer; 1997 Jan; 33 Suppl 1():S8-13. PubMed ID: 9166093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of gemcitabine as second-line chemotherapy in non-small cell lung cancer.
    Cok G; Göksel T; Soyer S; Aysan T
    Tuberk Toraks; 2008; 56(1):74-80. PubMed ID: 18330758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung Cancer Experts' Symposium. Proceedings. Stresa, Italy, October 1997.
    Semin Oncol; 1998 Aug; 25(4 Suppl 9):1-88. PubMed ID: 9728577
    [No Abstract]   [Full Text] [Related]  

  • 33. Multimodality treatment of unresectable stage III non-small cell lung cancer: interim analysis of a phase II trial with preoperative gemcitabine and concurrent radiotherapy.
    Galetta D; Cesario A; Margaritora S; Porziella V; Piraino A; D'Angelillo RM; Gambacorta MA; Ramella S; Trodella L; Valente S; Corbo GM; Macis G; Mulè A; Cardaci V; Sterzi S; Granone P; Russo P
    J Thorac Cardiovasc Surg; 2006 Feb; 131(2):314-21. PubMed ID: 16434259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gemcitabine as single agent chemotherapy in elderly patients with stages III-IV non-small cell lung cancer (NSCLC): a phase II study.
    Bianco V; Rozzi A; Tonini G; Santini D; Magnolfi E; Vincenzi B; D'Angelillo R; Marchei P
    Anticancer Res; 2002; 22(5):3053-6. PubMed ID: 12530041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Commentary on "Gemcitabine: single-agent and combination therapy in non-small cell lung cancer". The Oncologist 1999;4:241-251.
    Edelman MJ
    Oncologist; 1999; 4(3):252-5. PubMed ID: 10394592
    [No Abstract]   [Full Text] [Related]  

  • 36. The emerging role of gemcitabine in lung cancer: part I.
    Bunn PA
    Semin Oncol; 1997 Apr; 24(2 Suppl 7):S7-1. PubMed ID: 9194472
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
    Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
    Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gemcitabine as single agent in the treatment of elderly patients with advanced non small cell lung cancer.
    Altavilla G; Adamo V; Buemi B; Marabello G; Maisano R; Lupo G; Bene A; Bellocco G
    Anticancer Res; 2000; 20(5C):3675-8. PubMed ID: 11268438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer.
    Reynolds C; Obasaju C; Schell MJ; Li X; Zheng Z; Boulware D; Caton JR; Demarco LC; O'Rourke MA; Shaw Wright G; Boehm KA; Asmar L; Bromund J; Peng G; Monberg MJ; Bepler G
    J Clin Oncol; 2009 Dec; 27(34):5808-15. PubMed ID: 19884554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.